Azar and Hahn haven’t exactly been supportive of CYDY. Personally I think it’s gone beyond just remaining neutral given the support that Gilead got with Remdesivir despite mediocre results.
If the results are slow walked until the new HHS secretary is seated that might be a very good thing.